1E Therapeutics (1Etx) is a breakthrough drug development company creating first-in-class RNA-targeting therapeutics based on our proprietary drug design platform. 1E is the culmination of years of innovation, effort, and tens of millions of $US investment in research and development.
1E's proprietary and groundbreaking rapid drug design process has proven uniquely able to develop innovative drugs that address chronic life threatening indications as well as emerging and evolving pathogens. 1E already has lead compounds that address a wide array of indications in oncology, age-related diseases, anti-microbial resistance, and neurological disorders.
Company Details
- Employees
- 44
- Founded
- -
- Address
- Rehovot, Il
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.1etx.com
- Keywords
- Representative jobs.
- HQ
- Rehovot
1e Therapeutics Questions
1E Therapeutics's website is http://www.1etx.com
1E Therapeutics's LinkedIn profile is https://il.linkedin.com/company/1etx
1E Therapeutics has
44 employees.
View email and phone details for 44
employees at 1E Therapeutics.
1E Therapeutics's industry is
Pharmaceutical Manufacturing
1E Therapeutics's top competitors are
Enzymit,
Evogene,
Nucleix Ltd.,
Cytoreason,
Anima Biotech,
Memed,
Biomx (Nyse: Phge),
Prilenia,
Aummune,
Wild Biotech.
1E Therapeutics's categories are Pharmaceutical Manufacturing
1E Therapeutics's founding year is 2020
